LSE - Delayed Quote GBp

Surgical Innovations Group plc (SUN.L)

0.7000
0.0000
(0.00%)
At close: May 28 at 4:06:07 PM GMT+1
Loading Chart for SUN.L
  • Previous Close 0.7000
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.9800
  • Volume 25,000
  • Avg. Volume 658,462
  • Market Cap (intraday) 6.53M
  • Beta (5Y Monthly) 0.22
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date May 30, 2025 - Jun 4, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Surgical Innovations Group plc, together with its subsidiaries, engages in the design, manufacture, and export of medical products for use in laparoscopic and robotic minimally invasive surgery in the United Kingdom, Europe, the Asia Pacific, the United States, and internationally. It operates through three segments: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The company offers YelloPort Elite port access systems; YelloPort +plus Resposable port access systems; LogiCut, a disposable laparoscopic insert; Logic, a reusable laparoscopic grasping forceps and dissectors; LogiFlex, a dual purpose, Resposable device for blunt dissection and gastric band retrieval; FastClamp, a reusable laparoscopic clamping system, designed to fixate a range of instrumentation in position during minimally invasive surgery; PretzelFlex, a pretzel shaped organ and tissue retractor, designed for use in minimally invasive surgery; and LogiTube, a calibration tubing for gastric pouch sizing during sleeve gastrectomy, mini gastric bypass/one-anastomosis gastric bypass, or revision surgery for these procedures. It also researches, develops, manufactures, and distributes minimally invasive devices for third party medical device companies through either own label or co-branding; minimally invasive technology products for precision engineering applications; and services for design and build of instruments. In addition, the company distributes specialist medical products; and designs and manufactures autologous blood products. It sells its products through independent healthcare distributors, as well as its own label products through OEM relationships. The company was incorporated in 1988 and is headquartered in Leeds, the United Kingdom.

www.sigroupplc.com

80

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SUN.L

View more

Performance Overview: SUN.L

Trailing total returns as of 5/28/2025, which may include dividends or other distributions. Benchmark is FTSE 100 (^FTSE) .

YTD Return

SUN.L
27.27%
FTSE 100 (^FTSE)
6.77%

1-Year Return

SUN.L
40.00%
FTSE 100 (^FTSE)
5.72%

3-Year Return

SUN.L
66.67%
FTSE 100 (^FTSE)
15.04%

5-Year Return

SUN.L
48.15%
FTSE 100 (^FTSE)
40.32%

Compare to: SUN.L

Select to analyse similar companies using key performance metrics; select up to four stocks.

Statistics: SUN.L

View more

Valuation Measures

Annual
As of 5/27/2025
  • Market Cap

    6.53M

  • Enterprise Value

    7.69M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.52

  • Price/Book (mrq)

    0.65

  • Enterprise Value/Revenue

    0.61

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -4.96%

  • Return on Assets (ttm)

    -3.03%

  • Return on Equity (ttm)

    -6.04%

  • Revenue (ttm)

    12.54M

  • Net Income Avi to Common (ttm)

    -622k

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    232k

  • Total Debt/Equity (mrq)

    13.96%

  • Levered Free Cash Flow (ttm)

    -499.62k

Research Analysis: SUN.L

View more

Company Insights: SUN.L

Research reports: SUN.L

View more

People Also Watch